ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Novo Nordisk Pharma AG - Ryzodeg Penfill, Injektionslösung
6262701
Ryzodeg PenfillInjektionslösung
A10AD06Insulin Degludec and Insulin Aspart
12.09.2013  
Composition
insulinum degludecum 420 nmol corresp. insulinum degludecum 70 U., insulinum aspartum 180 nmol corresp. insulinum aspartum 30 U., glycerolum, natrii chloridum, zincum ut zinci acetas dihydricus, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabilia q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution
Aqua Ad Iniectabilia Q.s. Ad Solutionem
 
Active AgentDose
Insulin Aspart180  correspond Insulin Aspart 30 U
Insulinum Degludecum420  correspond Insulinum Degludecum 70 U
Nmol 
 
Inactive agentsDoseadditional_information
Glycerol  
Metacresol1.72 mg/ml 
Sodium Chloride  
Phenol1.5 mg/mlconserv.
Zincum  
Package numberPackage SizeEFPCPCategorySLOut of trade (MedRef)
0015 x 3 ml78.67106.70BSLNo
2019 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home